Cabergoline vs bromocriptine

In general, cabergoline is recommended over bromocriptine because of efficacy and fewer adverse effects but bromocriptine may be recommended if cost is an

Multicenter, multinational double‐blind study of the activity and tolerability of cabergoline vs bromocriptine in parkinsonian patients suffering from L‐dopa

Clomifene citrate (Clomid) Metformin Gonadotrophins Bromocriptine and Cabergoline Antioxidants and vitamins.

For the most common microadenomas, that is, prolactinomas, administer a dopaminergic drug such as bromocriptine or cabergoline.

Cabergoline vs Bromocriptine. The European multicenter study and Giorda et al have both reached the same conclusion that 1 mg of cabergoline given as a single oral dose is non-inferior to 5 mg daily for 14 days of bromocriptine in preventing puerperal lactation.

Cabergoline is an ergoline derivative with a high affinity and selectivity for D2 receptors. Unlike bromocriptine, cabergoline has low

Results: At the end of the study, the prolactin reduction was significantly greater in the cabergoline group than in the bromocriptine group (-93 vs. -87.5 %, respectively, p 0.05). Normalization of prolactin levels was achieved in 10 of 17 patients (59%) in the bromocriptine group, and in 14 of 17 patients (82%) in the cabergoline group (p

dopamine agonists, such as bromocriptine or cabergoline; dopamine antagonists, such as antipsychotics (such as butyrophenones, phenothiazines

The two approved medications for prolactinoma are bromocriptine and cabergoline . They are dopamine agonists.